PSMA-11
CAS: 1366302-52-4
Ref. 3D-REC30252
| 1mg | 341.00 € | ||
| 2mg | 455.00 € | ||
| 5mg | 895.00 € | ||
| 10mg | 1,403.00 € | ||
| 25mg | 2,232.00 € |
Product Information
PSMA-11 is a positron-emitting metal chelate that is used in the diagnosis of prostate cancer. It is administered as a diagnostic agent and has been shown to be clinically relevant for prostate cancer diagnosis. PSMA-11 has shown to have pharmacokinetic properties that can be retrospectively analyzed by measuring the amount of radioactivity in the patient's urine, which is indicative of the amount of PSMA-11 absorbed by the body. This biomarker can also be used for assessing the effectiveness of radiation therapy in patients with prostate cancer. PSMA-11 has been shown to bind to the human serum albumin, which may contribute to its pharmacokinetic properties. The imaging properties of PSMA-11 are still being explored but it has been found to show promise for use as a diagnostic agent in early stages of prostate cancer.
Chemical properties
Technical inquiry about: 3D-REC30252 PSMA-11
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
